ISN
Click for more information
9.09% 6.0¢ isonea limited

Ann: Appendix 4C - Quarterly Cashflow Report (Oct, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Snowy101
    755 Posts.
    clock Created with Sketch.
    03/02/14
    17:29
    Post #: 12887638
    re: Ann: Appendix 4C - Quarterly Cashflow Rep...
    Shocking result.

    Board changes, social media etc will not take this to the dizzying heights that some here are stating.

    Affordability for the average income family is not there.

    This product should have been trialled in clinical testing, have the backing of AMA, Asthma Australia, and the Asthma Foundation then released to the market.

    IMO DYOR
    ISN Price at posting: 32.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.